?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener
Filter & Suche
518 Ergebnisse (1 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
518 Unternehmen gefunden • Seite 4 von 21
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Otsuka Holdings Co Ltd ADR | 68.7 | Arzneimittel (Pharmazeutisch) | Japan | 38.8 Mrd. USD | 14.49 | 18.19 | 2.24 | 1.84 | ▲ 12.72% | ▲ 20.78% | 1.43% | ▼ -60.26% | - | 14.71% | ▲ 1.97% | 16.71% | ▲ 1.80% | 12.79% | ▲ 1.38% | 7 / 9 | 6,87 | 23-fach | 45 / 100 | −1,0 / 100 | −2,47 |
 | Roche Holding AG | 68.6 | Arzneimittel (Pharmazeutisch) | Schweiz | 343.7 Mrd. USD | 22.76 | 19.03 | 4.61 | 8.59 | ▲ 1.07% | ▼ -2.06% | 2.78% | ▲ 1.49% | 29 Jahre | 20.94% | ▼ -0.81% | 31.32% | ▼ -0.02% | 22.89% | ▼ -0.78% | 6 / 9 | 4,22 | 14-fach | 47 / 100 | −5,1 / 100 | −2,76 |
 | Alkermes Plc | 68.0 | Arzneimittel (Biotechnologie) | Irland | 7.7 Mrd. USD | 116.63 | 34.80 | 4.62 | 4.26 | ▲ 7.28% | - | - | - | - | 16.37% | ▲ 7.88% | 17.21% | ▲ 4.53% | 32.55% | ▲ 8.03% | 7 / 9 | 6,14 | 21-fach | 51 / 100 | −11,0 / 100 | −3,63 |
 | Rigel Pharmaceuticals Inc | 67.9 | Arzneimittel (Biotechnologie) | USA | 0.9 Mrd. USD | 2.74 | 11.12 | 3.19 | 2.07 | ▲ 22.06% | - | - | - | - | 124.72% | ▲ 33.19% | 42.63% | ▲ 16.17% | 25.71% | ▲ 12.34% | 7 / 9 | 0,36 | 6-fach | 53 / 100 | 56,7 / 100 | 1,58 |
 | Pharmaron Beijing Co Ltd | 67.8 | Arzneimittel (Biotechnologie) | China | 11.0 Mrd. USD | 43.21 | - | 4.87 | 4.53 | ▲ 22.39% | ▲ 7.25% | 0.50% | - | - | 11.80% | ▼ -1.98% | 15.78% | ▼ -1.92% | 3.92% | ▲ 2.10% | 8 / 9 | 2,73 | 10-fach | 19 / 100 | −5,9 / 100 | −2,93 |
 | Siegfried Holding Ltd | 67.8 | Arzneimittel (Pharmazeutisch) | Schweiz | 3.8 Mrd. USD | 18.06 | - | 2.31 | 3.11 | ▲ 9.46% | ▲ 22.61% | 0.57% | - | 10 Jahre | 12.70% | ▲ 0.77% | 15.84% | ▲ 0.50% | 0.75% | ▼ -0.28% | 6 / 9 | 5,20 | 22-fach | 16 / 100 | −2,5 / 100 | −2,44 |
 | Keros Therapeutics Inc | 67.7 | Arzneimittel (Biotechnologie) | USA | 0.2 Mrd. USD | - | - | 6.62 | 0.84 | ▲ 149.98% | - | - | - | - | 35.65% | ▼ -409.83% | 28.94% | ▼ -474.62% | 43.41% | ▼ -351.40% | 6 / 9 | 12,03 | - | 72 / 100 | −6,1 / 100 | 4,29 |
| Shandong Shanda Wit Science and Technology Co Ltd | 67.7 | Arzneimittel (Pharmazeutisch) | China | 0.9 Mrd. USD | 13.76 | 23.40 | 3.04 | 2.21 | ▲ 4.12% | ▲ 12.97% | 10.11% | - | - | 24.01% | ▲ 1.22% | 53.55% | ▲ 3.21% | 54.89% | ▲ 4.13% | 8 / 9 | 14,97 | > 50-fach | 54 / 100 | −21,0 / 100 | −4,11 |
 | Biomerieux SA | 67.6 | Arzneimittel (Biotechnologie) | Frankreich | 9.6 Mrd. USD | 17.95 | 14.18 | 2.08 | 1.93 | ▲ 5.47% | ▼ -0.34% | 1.37% | ▲ 9.59% | 1 Jahre | 9.77% | ▼ -1.78% | 13.79% | ▼ -1.87% | 11.13% | ▼ -0.58% | 6 / 9 | 5,56 | 44-fach | 38 / 100 | −7,0 / 100 | −2,74 |
| Hubei Jumpcan Pharmaceutical Co Ltd | 67.5 | Arzneimittel (Pharmazeutisch) | China | 3.4 Mrd. USD | 12.44 | - | 3.94 | 1.66 | ▲ 0.17% | ▲ 6.84% | 7.02% | - | 1 Jahre | 28.59% | ▲ 1.96% | 30.19% | ▲ 1.85% | 17.73% | ▼ -0.91% | 5 / 9 | 11,87 | > 50-fach | 28 / 100 | 3,3 / 100 | −3,21 |
 | Sk Biopharmaceuticals Co Ltd | 67.2 | Arzneimittel (Biotechnologie) | Südkorea | 4.3 Mrd. USD | 15.51 | 28.68 | 7.22 | 6.09 | ▲ 93.58% | - | - | - | - | 37.77% | ▲ 14.52% | 28.86% | ▲ 8.32% | 20.77% | ▲ 16.98% | 6 / 9 | 4,37 | 8-fach | 56 / 100 | 7,6 / 100 | −1,67 |
 | Basilea Pharmaceutica AG | 67.1 | Arzneimittel (Biotechnologie) | Schweiz | 1.0 Mrd. USD | 15.78 | 14.95 | 3.34 | 5.09 | ▲ 12.73% | - | - | - | - | 17.31% | ▲ 7.28% | 22.20% | ▲ 5.96% | 25.49% | ▲ 12.77% | 7 / 9 | −3,45 | 7-fach | 68 / 100 | −7,8 / 100 | −2,85 |
 | Halozyme Therapeutics Inc | 67.0 | Arzneimittel (Biotechnologie) | USA | 12.2 Mrd. USD | 29.42 | 15.09 | 7.31 | 84.76 | ▲ 39.16% | ▲ 19.68% | - | - | - | 22.69% | ▼ -12.32% | 58.45% | ▲ 0.62% | 46.15% | ▼ -3.16% | 6 / 9 | 3,07 | 26-fach | 43 / 100 | −13,3 / 100 | −2,51 |
| Innovent Biologics Inc | 66.8 | Arzneimittel (Biotechnologie) | China | 20.8 Mrd. USD | 114.87 | 14.80 | 8.95 | 6.73 | ▲ 27.68% | - | - | - | - | 6.24% | ▲ 20.63% | 5.63% | ▲ 21.18% | 71.45% | ▲ 39.23% | 7 / 9 | 2,45 | −0,6-fach | 27 / 100 | −25,1 / 100 | −3,45 |
 | Galapagos N.V. | 66.8 | Arzneimittel (Biotechnologie) | Belgien | 1.8 Mrd. USD | 3.18 | - | 1.49 | 0.48 | ▲ 18.40% | - | - | - | - | 28.85% | ▲ 17.03% | 42.23% | ▲ 13.74% | -18.94% | ▲ 15.43% | 7 / 9 | 26,34 | > 50-fach | 30 / 100 | 15,2 / 100 | 0,13 |
 | BB Biotech AG | 66.8 | Arzneimittel (Biotechnologie) | Schweiz | 3.5 Mrd. USD | 2.15 | 9.56 | 19.83 | 0.94 | ▼ -35.71% | ▼ -3.51% | 4.29% | ▼ -8.97% | - | 752.66% | ▲ 126.71% | 763.99% | ▲ 129.79% | 402.47% | ▲ 77.16% | - | 423,26 | 41-fach | 3 / 100 | 9,7 / 100 | - |
 | Krystal Biotech Inc | 66.7 | Arzneimittel (Biotechnologie) | USA | 10.3 Mrd. USD | 42.54 | 39.84 | 23.32 | 7.56 | - | - | - | - | - | 52.64% | - | 41.45% | - | 48.55% | - | 6 / 9 | 16,76 | unbegrenzt | 27 / 100 | 0,3 / 100 | −2,26 |
| Tsumura & Co | 66.5 | Arzneimittel (Pharmazeutisch) | Japan | 2.4 Mrd. USD | 22.21 | - | 2.46 | 1.37 | ▲ 10.60% | ▲ 12.89% | 2.32% | ▲ 19.81% | 3 Jahre | 14.60% | ▲ 0.63% | 18.29% | ▲ 0.92% | -5.01% | ▼ -2.56% | 4 / 9 | 6,75 | > 50-fach | 17 / 100 | 0,6 / 100 | −1,97 |
| Hanmi Pharm Co Ltd | 66.3 | Arzneimittel (Pharmazeutisch) | Südkorea | 4.1 Mrd. USD | 27.11 | 32.27 | 3.55 | 4.19 | ▲ 7.54% | ▲ 69.95% | 0.43% | - | - | 10.96% | ▲ 1.27% | 16.66% | ▲ 1.51% | 6.24% | ▼ -1.89% | 8 / 9 | 4,98 | 9-fach | 45 / 100 | −0,2 / 100 | −2,08 |
 | Biomarin Pharmaceutical Inc | 66.2 | Arzneimittel (Biotechnologie) | USA | 12.7 Mrd. USD | 174.23 | 17.35 | 3.73 | 2.01 | ▲ 11.60% | ▼ -16.49% | - | - | - | 10.83% | ▲ 3.68% | 16.56% | ▲ 5.13% | 22.51% | ▲ 3.90% | 6 / 9 | 7,50 | 31-fach | 33 / 100 | −6,3 / 100 | −2,67 |
 | AbbVie Inc | 66.1 | Arzneimittel (Biotechnologie) | USA | 454.4 Mrd. USD | 71.96 | 25.04 | 7.06 | -76.56 | ▲ 5.95% | ▼ -1.75% | 2.69% | ▲ 5.88% | 12 Jahre | 6.91% | ▼ -4.01% | 32.85% | ▼ -1.31% | 29.13% | ▼ -3.01% | 8 / 9 | −0,62 | 3-fach | 32 / 100 | −11,1 / 100 | −2,94 |
 | Rhythm Pharmaceuticals Inc | 66.1 | Arzneimittel (Biotechnologie) | USA | 7.2 Mrd. USD | - | - | 30.05 | 33.18 | ▲ 458.25% | ▲ 8.50% | - | - | - | -103.57% | ▲ 467.12% | -101.19% | ▲ 1113.52% | -61.46% | ▲ 1014.42% | 6 / 9 | −5,35 | −10,6-fach | 35 / 100 | −16,8 / 100 | −2,97 |
| Mayinglong Pharmaceutical Group Co Ltd | 66.0 | Arzneimittel (Pharmazeutisch) | China | 1.4 Mrd. USD | 16.15 | 53.17 | 2.44 | 2.08 | ▲ 6.73% | ▲ 6.77% | 3.01% | ▲ 8.76% | 3 Jahre | 15.04% | ▲ 0.32% | 17.32% | ▲ 0.43% | 12.44% | ▼ -0.62% | 8 / 9 | 11,89 | > 50-fach | 36 / 100 | −0,4 / 100 | −3,33 |
 | PTC Therapeutics Inc | 65.6 | Arzneimittel (Biotechnologie) | USA | 5.5 Mrd. USD | - | - | 5.47 | -33.34 | ▲ 35.37% | - | - | - | - | 39.44% | ▲ 30.84% | 49.49% | ▲ 26.45% | 23.76% | ▲ 22.28% | 7 / 9 | 1,52 | 0-fach | 57 / 100 | −1,0 / 100 | −1,66 |
 | Astellas Pharma Inc | 65.4 | Arzneimittel (Pharmazeutisch) | Japan | 26.1 Mrd. USD | 10.45 | 7.30 | 1.67 | 2.08 | ▲ 12.67% | ▲ 20.72% | 3.40% | ▼ -61.70% | - | 13.63% | ▲ 0.43% | 19.62% | ▼ -0.14% | 23.77% | ▲ 1.10% | 8 / 9 | 3,08 | 11-fach | 47 / 100 | −8,1 / 100 | −2,67 |
